| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Oak Ridge Conference |
1
Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20852.
2
Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd., Rm. EPN 330F, Rockville, MD 20852.
3
Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109.
4
Department of Microbiology and Molecular Cell Biology and Virginia Prostate Center, Eastern Virginia Medical School, Norfolk, VA 23501.
aAuthor for correspondence. Fax 301-402-0816; e-mail ss1a{at}nih.gov.
Abstract
Early detection is critical in cancer control and prevention. Biomarkers help in this process by providing valuable information about a the status of a cell at any given point in time. As a cell transforms from nondiseased to neoplastic, distinct changes occur that could be potentially detected through the identification of the appropriate biomarkers. Biomarker research has benefited from advances in technology such as proteomics. We discuss here ongoing research in this field, focusing on proteomic technologies. The advances in two-dimensional electrophoresis and mass spectrometry are discussed in light of their contribution to biomarker research. Chip-based techniques, such as surface-enhanced laser desorption, and ionization and emerging methods, such as tissue and antibody arrays, are also discussed. The development of bioinformatic tools that have and are being developed in parallel to proteomics is also addressed. This report brings into focus the efforts of the Early Detection Research Network at the National Cancer Institute in harnessing scientific expertise from leading institutions to identify and validate biomarkers for early detection and risk assessment.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  H. K. Kim, W. S. Park, S. H. Kang, M. Warda, N. Kim, J.-H. Ko, A. E.-b. Prince, and J. Han Mitochondrial alterations in human gastric carcinoma cell line Am J Physiol Cell Physiol, August 1, 2007; 293(2): C761 - C771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Lopez, A. Mikulskis, S. Kuzdzal, E. Golenko, E. F. Petricoin III, L. A. Liotta, W. F. Patton, G. R. Whiteley, K. Rosenblatt, P. Gurnani, et al. A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples Clin. Chem., June 1, 2007; 53(6): 1067 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bloomston, J. X. Zhou, A. S. Rosemurgy, W. Frankel, C. A. Muro-Cacho, and T. J. Yeatman Fibrinogen {gamma} Overexpression in Pancreatic Cancer Identified by Large-scale Proteomic Analysis of Serum Samples. Cancer Res., March 1, 2006; 66(5): 2592 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le, K. Chi, S. Tyldesley, S. Flibotte, D. L. Diamond, M. A. Kuzyk, and M. D. Sadar Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions Clin. Chem., April 1, 2005; 51(4): 695 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Koomen, L. N. Shih, K. R. Coombes, D. Li, L.-c. Xiao, I. J. Fidler, J. L. Abbruzzese, and R. Kobayashi Plasma Protein Profiling for Diagnosis of Pancreatic Cancer Reveals the Presence of Host Response Proteins Clin. Cancer Res., February 1, 2005; 11(3): 1110 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Mateos-Caceres, A. Garcia-Mendez, A. Lopez Farre, C. Macaya, A. Nunez, J. Gomez, S. Alonso-Orgaz, C. Carrasco, M. E. Burgos, R. de Andres, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1578 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, G. Shi, W. Xia, C. Kong, S. Zhao, A. F. Gaw, E. Y. Chen, G. P. Yang, A. J. Giaccia, Q.-T. Le, et al. Identification of Hypoxia-Regulated Proteins in Head and Neck Cancer by Proteomic and Tissue Array Profiling Cancer Res., October 15, 2004; 64(20): 7302 - 7310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Skates and O. Iliopoulos Molecular Markers for Early Detection of Renal Carcinoma: Investigative Approach Clin. Cancer Res., September 15, 2004; 10(18): 6296S - 6301S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kinpara, R. Mizuno, Y. Murakami, M. Kobayashi, S. Yamaura, Q. Hasan, Y. Morita, H. Nakano, T. Yamane, and E. Tamiya A Picoliter Chamber Array for Cell-Free Protein Synthesis J. Biochem., August 1, 2004; 136(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Z. Kristiansen, J. Bunkenborg, M. Gronborg, H. Molina, P. J. Thuluvath, P. Argani, M. G. Goggins, A. Maitra, and A. Pandey A Proteomic Analysis of Human Bile Mol. Cell. Proteomics, July 1, 2004; 3(7): 715 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Soriano and J. D. Pardee M34 Actin Regulatory Protein Is a Sensitive Diagnostic Marker for Early- and Late-Stage Mammary Carcinomas Clin. Cancer Res., July 1, 2004; 10(13): 4437 - 4443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations Mol. Cell. Proteomics, April 1, 2004; 3(4): 367 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tomonaga, K. Matsushita, S. Yamaguchi, M. Oh-Ishi, Y. Kodera, T. Maeda, H. Shimada, T. Ochiai, and F. Nomura Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis Clin. Cancer Res., March 15, 2004; 10(6): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Diamandis Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems J Natl Cancer Inst, March 3, 2004; 96(5): 353 - 356. [Full Text] [PDF]
|
|
|
|
|
|
J. T. Wadsworth, K. D. Somers, L. H. Cazares, G. Malik, B.-L. Adam, B. C. Stack Jr., G. L. Wright Jr., and O. J. Semmes Serum Protein Profiles to Identify Head and Neck Cancer Clin. Cancer Res., March 1, 2004; 10(5): 1625 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Wadsworth, K. D. Somers, B. C. Stack Jr, L. Cazares, G. Malik, B.-L. Adam, G. L. Wright Jr, and O. J. Semmes Identification of Patients With Head and Neck Cancer Using Serum Protein Profiles Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics? Clin. Chem., August 1, 2003; 49(8): 1272 - 1275. [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Sheffield and J. J. Gavinski Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction J Dairy Sci, July 1, 2003; 86(13_suppl): E115 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C.W. Poon, T.-T. Yip, A. T.C. Chan, C. Yip, V. Yip, T. S.K. Mok, C. C.Y. Lee, T. W.T. Leung, S. K.W. Ho, and P. J. Johnson Comprehensive Proteomic Profiling Identifies Serum Proteomic Signatures for Detection of Hepatocellular Carcinoma and Its Subtypes Clin. Chem., May 1, 2003; 49(5): 752 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Sheffield and J. J. Gavinski Proteomics methods for probing molecular mechanisms in signal transduction J Anim Sci, March 1, 2003; 81(suppl_3): 48 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sasaki, K. Sato, Y. Akiyama, K. Yanagihara, M. Oka, and K. Yamaguchi Peptidomics-based Approach Reveals the Secretion of the 29-Residue COOH-Terminal Fragment of the Putative Tumor Suppressor Protein DMBT1 from Pancreatic Adenocarcinoma Cell Lines Cancer Res., September 1, 2002; 62(17): 4894 - 4898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-L. Adam, Y. Qu, J. W. Davis, M. D. Ward, M. A. Clements, L. H. Cazares, O. J. Semmes, P. F. Schellhammer, Y. Yasui, Z. Feng, et al. Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men Cancer Res., July 1, 2002; 62(13): 3609 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Macoska The Progressing Clinical Utility of DNA Microarrays CA Cancer J Clin, January 1, 2002; 52(1): 50 - 59. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
